Annika I. Johansson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Annika I. Johansson has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Folke Sitbon
Department of Plant Biology Uppsala BioCenter, Swedish University of Agricultural Sciences Uppsala Sweden
2 shared publications - Irene Merino
Department of Plant Biology Uppsala BioCenter, Swedish University of Agricultural Sciences Uppsala Sweden
2 shared publications - Mariette Andersson
Department of Plant Breeding, Swedish University of Agricultural Sciences, P.O. Box 190, SE-234 22 Lomma, Sweden
2 shared publications - Per Hofvander
Department of Plant Breeding, Swedish University of Agricultural Sciences , Alnarp SE-230 53
2 shared publications - Ying Liu
Department of Plant Breeding Swedish University of Agricultural Sciences Lomma Sweden
2 shared publications Adam Flöhr
1 shared publication
Latest Publications
- Open Access
- 20 July 2026
- Published by Elsevier in Plant Physiology and Biochemistry
- Vol. 237
Loss of function of the AP2/ERF transcription factor StGAME9 abolishes activation and induction of steroidal glycoalkaloid biosynthesis in potato plants
- 20 July 2026
- Published by Elsevier in Plant Physiology and Biochemistry
- Vol. 237
Open AccessLoss of function of the AP2/ERF transcription factor StGAME9 abolishes activation and induction of steroidal glycoalkaloid biosynthesis in potato plants
- Open Access
Proteomic profiling reveals pleiotropic antimetabolite activity of triciribine in acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) exhibits marked genetic and metabolic heterogeneity that limits the efficacy of targeted therapies. Antimetabolite strategies remain central to ALL treatment, yet the mechanisms underlying differential drug sensitivity are incompletely defined. Here, we investigated the activity of the purine analog triciribine (TCN) across diverse ALL cellular models. We find that TCN exerts potent cytotoxic effects in multiple ALL cell lines, exceeding those observed with canonical Akt inhibitors in our datasets. Phosphoproteomic analyses indicate that, at early time points, TCN does not primarily suppress Akt signaling but instead induces transient pathway activation accompanied by inhibition of cyclin-dependent kinases in both sensitive and resistant cells. The monophosphorylated metabolite TCN-P represents the predominant intracellular species and requires adenosine kinase (ADK) for activity, with ADK protein levels positively correlating with TCN sensitivity in both cell lines and primary patient samples. Using Proteome Integral Solubility Alteration profiling, we identify candidate protein interactions of TCN-P distributed across multiple cellular pathways, including nucleotide metabolism, DNA replication, and protein synthesis. These interactions are accompanied by impaired purine biosynthesis, DNA damage, translational stress, and cell-cycle arrest, as supported by time-course quantitative proteomics and immunoblot analyses. Together, these findings characterize triciribine as an antileukemic agent with pleiotropic antimetabolite activity in ALL and highlight ADK-dependent metabolism as a key determinant of therapeutic sensitivity, suggesting that ADK levels may serve as a predictive biomarker to stratify patients for triciribine-based precision treatment strategies.
Open AccessProteomic profiling reveals pleiotropic antimetabolite activity of triciribine in acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) exhibits marked genetic and metabolic heterogeneity that limits the efficacy of targeted therapies. Antimetabolite strategies remain central to ALL treatment, yet the mechanisms underlying differential drug sensitivity are incompletely defined. Here, we investigated the activity of the purine analog triciribine (TCN) across diverse ALL cellular models. We find that TCN exerts potent cytotoxic effects in multiple ALL cell lines, exceeding those observed with canonical Akt inhibitors in our datasets. Phosphoproteomic analyses indicate that, at early time points, TCN does not primarily suppress Akt signaling but instead induces transient pathway activation accompanied by inhibition of cyclin-dependent kinases in both sensitive and resistant cells. The monophosphorylated metabolite TCN-P represents the predominant intracellular species and requires adenosine kinase (ADK) for activity, with ADK protein levels positively correlating with TCN sensitivity in both cell lines and primary patient samples. Using Proteome Integral Solubility Alteration profiling, we identify candidate protein interactions of TCN-P distributed across multiple cellular pathways, including nucleotide metabolism, DNA replication, and protein synthesis. These interactions are accompanied by impaired purine biosynthesis, DNA damage, translational stress, and cell-cycle arrest, as supported by time-course quantitative proteomics and immunoblot analyses. Together, these findings characterize triciribine as an antileukemic agent with pleiotropic antimetabolite activity in ALL and highlight ADK-dependent metabolism as a key determinant of therapeutic sensitivity, suggesting that ADK levels may serve as a predictive biomarker to stratify patients for triciribine-based precision treatment strategies.
- Open Access
- 29 December 2025
- Published by Wiley in Physiologia Plantarum
- Vol. 178 (1) , e70723
L‐Glutamine Modulates Root Architecture and Hormonal Balance in Arabidopsis
Nitrogen (N) availability is a key determinant of plant growth and development. Here, we investigate how different N sources shape Arabidopsis thaliana root system architecture, metabolism and hormone dynamics. L‐glutamine (L‐GLN) significantly enhances root biomass compared to nitrate (KNO 3 ) without compromising shoot growth. This effect emerges after 2 weeks and is independent of L‐GLN's role as a carbon or ammonium source or of potential L‐GLN‐induced pH changes due to ammonium release, indicating a specific function of L‐GLN as a N source and signaling molecule. A reverse genetic screen identified AMINO ACID PERMEASE 1 (AAP1)‐mediated uptake and GLUTAMINE SYNTHETASE (GS)‐dependent assimilation as essential for L‐GLN‐induced root biomass. In contrast, the N‐sensing regulators NITRATE TRANSPORTER 1.1 (NRT1.1) and AMMONIUM TRANSPORTER (AMT) family members contribute to the differential root responses between KNO 3 and L‐GLN. Metabolic profiling revealed distinct amino acid signatures under these N sources, irrespective of genotype. Hormonal analyses showed that L‐GLN modulates auxin homeostasis, with auxin supplementation restoring primary root growth and lateral root symmetry under L‐GLN conditions. L‐GLN also reconfigures cytokinin balance by elevating cZ while reducing tZ, collectively shaping root system architecture through hormone‐dependent regulation. Together, these findings establish L‐GLN as an integrator of N metabolism and hormone signaling in root development, highlighting its signaling capacity beyond nutrient supply and offering new perspectives for improving N use efficiency.
- 29 December 2025
- Published by Wiley in Physiologia Plantarum
- Vol. 178 (1) , e70723
Open AccessL‐Glutamine Modulates Root Architecture and Hormonal Balance in Arabidopsis
Nitrogen (N) availability is a key determinant of plant growth and development. Here, we investigate how different N sources shape Arabidopsis thaliana root system architecture, metabolism and hormone dynamics. L‐glutamine (L‐GLN) significantly enhances root biomass compared to nitrate (KNO 3 ) without compromising shoot growth. This effect emerges after 2 weeks and is independent of L‐GLN's role as a carbon or ammonium source or of potential L‐GLN‐induced pH changes due to ammonium release, indicating a specific function of L‐GLN as a N source and signaling molecule. A reverse genetic screen identified AMINO ACID PERMEASE 1 (AAP1)‐mediated uptake and GLUTAMINE SYNTHETASE (GS)‐dependent assimilation as essential for L‐GLN‐induced root biomass. In contrast, the N‐sensing regulators NITRATE TRANSPORTER 1.1 (NRT1.1) and AMMONIUM TRANSPORTER (AMT) family members contribute to the differential root responses between KNO 3 and L‐GLN. Metabolic profiling revealed distinct amino acid signatures under these N sources, irrespective of genotype. Hormonal analyses showed that L‐GLN modulates auxin homeostasis, with auxin supplementation restoring primary root growth and lateral root symmetry under L‐GLN conditions. L‐GLN also reconfigures cytokinin balance by elevating cZ while reducing tZ, collectively shaping root system architecture through hormone‐dependent regulation. Together, these findings establish L‐GLN as an integrator of N metabolism and hormone signaling in root development, highlighting its signaling capacity beyond nutrient supply and offering new perspectives for improving N use efficiency.
- Open Access
- 18 October 2025
- Published by Wiley in Plant Biotechnology Journal
- Vol. 24 (3) , 1344-1358
Glycoalkaloid‐Free Starch Potatoes Generated by CRISPR /Cas9‐Mediated Mutations of Genes in the Glycoalkaloid Biosynthesis Pathway Enable More Sustainable Uses of By‐Products From Starch Production
Steroidal glycoalkaloids (SGAs) are toxic cholesterol‐derived secondary metabolites present in several Solanaceae species. In potato, tuber SGA levels are for reasons of toxicity of concern in both table and starch cultivars. In the latter, SGAs bind to proteins and fibres in starch production side‐streams and prevent their further uses as food and feed. To enable more sustainable uses of starch by‐products, we have here reduced SGA biosynthesis in a starch potato cultivar using DNA‐free CRISPR/Cas9. Six SGA genes were targeted, encoding enzymes acting either before cholesterol ( SMO1‐L , DWF1‐L , DWF7‐L ), or after ( 16DOX , CYP88B1 , TAMiso2 ). Editing efficiencies varied between 20% and 49%, and generated mutants were investigated under greenhouse and field conditions. Target mass‐spectrometric analyses confirmed reduced SGA levels and alterations of sterol metabolism in mutated events. Plant height and tuber yield were reduced in several events, although this was not correlated to low SGA levels. Several knockout mutants had almost SGA‐free leaves and tubers, the latter also under two SGA‐inducing conditions. Similarly, both fibre and protein fractions isolated from side‐streams in the starch production process from mutant tubers had very low SGA levels. By contrast, the corresponding wild‐type SGA levels were almost 10‐fold and, respectively, 40‐fold higher than the recommended upper safe limit. The results demonstrate that glycoalkaloid‐free mutants can be generated and grown with moderate yield reductions under both greenhouse and field conditions. This suggests a potential for sustainable production of high‐value products, e.g., food‐grade protein and fibre, from starch production side‐streams of SGA knockout tubers.
- 18 October 2025
- Published by Wiley in Plant Biotechnology Journal
- Vol. 24 (3) , 1344-1358
Open AccessGlycoalkaloid‐Free Starch Potatoes Generated by CRISPR /Cas9‐Mediated Mutations of Genes in the Glycoalkaloid Biosynthesis Pathway Enable More Sustainable Uses of By‐Products From Starch Production
Steroidal glycoalkaloids (SGAs) are toxic cholesterol‐derived secondary metabolites present in several Solanaceae species. In potato, tuber SGA levels are for reasons of toxicity of concern in both table and starch cultivars. In the latter, SGAs bind to proteins and fibres in starch production side‐streams and prevent their further uses as food and feed. To enable more sustainable uses of starch by‐products, we have here reduced SGA biosynthesis in a starch potato cultivar using DNA‐free CRISPR/Cas9. Six SGA genes were targeted, encoding enzymes acting either before cholesterol ( SMO1‐L , DWF1‐L , DWF7‐L ), or after ( 16DOX , CYP88B1 , TAMiso2 ). Editing efficiencies varied between 20% and 49%, and generated mutants were investigated under greenhouse and field conditions. Target mass‐spectrometric analyses confirmed reduced SGA levels and alterations of sterol metabolism in mutated events. Plant height and tuber yield were reduced in several events, although this was not correlated to low SGA levels. Several knockout mutants had almost SGA‐free leaves and tubers, the latter also under two SGA‐inducing conditions. Similarly, both fibre and protein fractions isolated from side‐streams in the starch production process from mutant tubers had very low SGA levels. By contrast, the corresponding wild‐type SGA levels were almost 10‐fold and, respectively, 40‐fold higher than the recommended upper safe limit. The results demonstrate that glycoalkaloid‐free mutants can be generated and grown with moderate yield reductions under both greenhouse and field conditions. This suggests a potential for sustainable production of high‐value products, e.g., food‐grade protein and fibre, from starch production side‐streams of SGA knockout tubers.
- Open Access
- 3 April 2023
- Published by Springer Nature in Nature Metabolism
- Vol. 5 (4) , 642-659
Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells
Cancer cells fuel their increased need for nucleotide supply by upregulating one-carbon (1C) metabolism, including the enzymes methylenetetrahydrofolate dehydrogenase–cyclohydrolase 1 and 2 (MTHFD1 and MTHFD2). TH9619 is a potent inhibitor of dehydrogenase and cyclohydrolase activities in both MTHFD1 and MTHFD2, and selectively kills cancer cells. Here, we reveal that, in cells, TH9619 targets nuclear MTHFD2 but does not inhibit mitochondrial MTHFD2. Hence, overflow of formate from mitochondria continues in the presence of TH9619. TH9619 inhibits the activity of MTHFD1 occurring downstream of mitochondrial formate release, leading to the accumulation of 10-formyl-tetrahydrofolate, which we term a ‘folate trap’. This results in thymidylate depletion and death of MTHFD2-expressing cancer cells. This previously uncharacterized folate trapping mechanism is exacerbated by physiological hypoxanthine levels that block the de novo purine synthesis pathway, and additionally prevent 10-formyl-tetrahydrofolate consumption for purine synthesis. The folate trapping mechanism described here for TH9619 differs from other MTHFD1/2 inhibitors and antifolates. Thus, our findings uncover an approach to attack cancer and reveal a regulatory mechanism in 1C metabolism.
- 3 April 2023
- Published by Springer Nature in Nature Metabolism
- Vol. 5 (4) , 642-659
Open AccessFormate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells
Cancer cells fuel their increased need for nucleotide supply by upregulating one-carbon (1C) metabolism, including the enzymes methylenetetrahydrofolate dehydrogenase–cyclohydrolase 1 and 2 (MTHFD1 and MTHFD2). TH9619 is a potent inhibitor of dehydrogenase and cyclohydrolase activities in both MTHFD1 and MTHFD2, and selectively kills cancer cells. Here, we reveal that, in cells, TH9619 targets nuclear MTHFD2 but does not inhibit mitochondrial MTHFD2. Hence, overflow of formate from mitochondria continues in the presence of TH9619. TH9619 inhibits the activity of MTHFD1 occurring downstream of mitochondrial formate release, leading to the accumulation of 10-formyl-tetrahydrofolate, which we term a ‘folate trap’. This results in thymidylate depletion and death of MTHFD2-expressing cancer cells. This previously uncharacterized folate trapping mechanism is exacerbated by physiological hypoxanthine levels that block the de novo purine synthesis pathway, and additionally prevent 10-formyl-tetrahydrofolate consumption for purine synthesis. The folate trapping mechanism described here for TH9619 differs from other MTHFD1/2 inhibitors and antifolates. Thus, our findings uncover an approach to attack cancer and reveal a regulatory mechanism in 1C metabolism.
- Open Access
- 12 April 2022
- Published by Springer Nature in The EMBO Journal
- Vol. 41 (10) , e109390
DGAT1 activity synchronises with mitophagy to protect cells from metabolic rewiring by iron depletion
Mitophagy removes defective mitochondria via lysosomal elimination. Increased mitophagy coincides with metabolic reprogramming, yet it remains unknown whether mitophagy is a cause or consequence of such state changes. The signalling pathways that integrate with mitophagy to sustain cell and tissue integrity also remain poorly defined. We performed temporal metabolomics on mammalian cells treated with deferiprone, a therapeutic iron chelator that stimulates PINK1/PARKIN‐independent mitophagy. Iron depletion profoundly rewired the metabolome, hallmarked by remodelling of lipid metabolism within minutes of treatment. DGAT1‐dependent lipid droplet biosynthesis occurred several hours before mitochondrial clearance, with lipid droplets bordering mitochondria upon iron chelation. We demonstrate that DGAT1 inhibition restricts mitophagy in vitro, with impaired lysosomal homeostasis and cell viability. Importantly, genetic depletion of DGAT1 in vivo significantly impaired neuronal mitophagy and locomotor function in Drosophila. Our data define iron depletion as a potent signal that rapidly reshapes metabolism and establishes an unexpected synergy between lipid homeostasis and mitophagy that safeguards cell and tissue integrity.
- 12 April 2022
- Published by Springer Nature in The EMBO Journal
- Vol. 41 (10) , e109390
Open AccessDGAT1 activity synchronises with mitophagy to protect cells from metabolic rewiring by iron depletion
Mitophagy removes defective mitochondria via lysosomal elimination. Increased mitophagy coincides with metabolic reprogramming, yet it remains unknown whether mitophagy is a cause or consequence of such state changes. The signalling pathways that integrate with mitophagy to sustain cell and tissue integrity also remain poorly defined. We performed temporal metabolomics on mammalian cells treated with deferiprone, a therapeutic iron chelator that stimulates PINK1/PARKIN‐independent mitophagy. Iron depletion profoundly rewired the metabolome, hallmarked by remodelling of lipid metabolism within minutes of treatment. DGAT1‐dependent lipid droplet biosynthesis occurred several hours before mitochondrial clearance, with lipid droplets bordering mitochondria upon iron chelation. We demonstrate that DGAT1 inhibition restricts mitophagy in vitro, with impaired lysosomal homeostasis and cell viability. Importantly, genetic depletion of DGAT1 in vivo significantly impaired neuronal mitophagy and locomotor function in Drosophila. Our data define iron depletion as a potent signal that rapidly reshapes metabolism and establishes an unexpected synergy between lipid homeostasis and mitophagy that safeguards cell and tissue integrity.
- Open Access
- 4 March 2022
- Published by Wiley in FEBS Letters
- Vol. 596 (12) , 1600-1610
Comparative structural analysis provides new insights into the function of R2‐like ligand‐binding oxidase
R2‐like ligand‐binding oxidase (R2lox) is a ferritin‐like protein that harbours a heterodinuclear manganese–iron active site. Although R2lox function is yet to be established, the enzyme binds a fatty acid ligand coordinating the metal centre and catalyses the formation of a tyrosine–valine ether cross‐link in the protein scaffold upon O2 activation. Here, we characterized the ligands copurified with R2lox by mass spectrometry‐based metabolomics. Moreover, we present the crystal structures of two new homologs of R2lox, from Saccharopolyspora erythraea and Sulfolobus acidocaldarius, at 1.38 Å and 2.26 Å resolution, respectively, providing the highest resolution structure for R2lox, as well as new insights into putative mechanisms regulating the function of the enzyme.
- 4 March 2022
- Published by Wiley in FEBS Letters
- Vol. 596 (12) , 1600-1610
Open AccessComparative structural analysis provides new insights into the function of R2‐like ligand‐binding oxidase
R2‐like ligand‐binding oxidase (R2lox) is a ferritin‐like protein that harbours a heterodinuclear manganese–iron active site. Although R2lox function is yet to be established, the enzyme binds a fatty acid ligand coordinating the metal centre and catalyses the formation of a tyrosine–valine ether cross‐link in the protein scaffold upon O2 activation. Here, we characterized the ligands copurified with R2lox by mass spectrometry‐based metabolomics. Moreover, we present the crystal structures of two new homologs of R2lox, from Saccharopolyspora erythraea and Sulfolobus acidocaldarius, at 1.38 Å and 2.26 Å resolution, respectively, providing the highest resolution structure for R2lox, as well as new insights into putative mechanisms regulating the function of the enzyme.